Vol. 24 No. 4 (2019)

Article

• Transforming Technology Into High-Value Solutions for Compelling Biomedical Needs: Bio Entrepreneurship Bootcamp 2.0

  Arthur A. Boni

  • Requires Subscription PDF (USD 25)

• Evolution of the Screening Metaphor: Project, Product, or Platform?

  Arthur A. Boni

  • Requires Subscription PDF (USD 25)

• Aligning the Corporation for Transformative Innovation: Introducing Innovation Dashboard 2.0

  Arthur A. Boni, Diana Joseph

  • Requires Subscription PDF (USD 25)

• Four Models for Corporate Transformative, Open Innovation

  Arthur A. Boni, Diana Joseph

  • Requires Subscription PDF (USD 25)

• IP Fundamentals – What Every CEO Should Know About IP in Biotechnology

  Kathryn Doyle

  • Requires Subscription PDF (USD 25)

• Intellectual Property for Life Science Entrepreneurs

  Raymond A. Miller

  • Requires Subscription PDF (USD 25)

• Intellectual Property – Solidify Your Competitive Edge

  James Jordan

  • Requires Subscription PDF (USD 25)

• 2018 Mostly a Sideways Market Masking a Lot of Excitement: Innovation and Science Keep the Party Rolling

  Edwin Gordon

  • Requires Subscription PDF (USD 25)

• Founding and Funding a Life Sciences Company: An Overview

  James Jordan, David Smith

  • Requires Subscription PDF (USD 25)

• Strategic Planning for Financing and Growing Biotechnology Companies Strategic Planning for Financing and Growing Biotechnology Companies

  Claudine Kearney

  • Requires Subscription PDF (USD 25)

• “The Good, the Bad, the Ugly”: Leadership Lessons From two Companies – Amgen and Theranos

  Arthur A. Boni, Stephen Sammut

  • Requires Subscription PDF (USD 25)

• Leading and Managing Teams in Entrepreneurial Organizations: an Experiential Perspective

  Arthur A. Boni

  • Requires Subscription PDF (USD 25)

• Building and Managing Great Teams: An Evidence-Based Approach

  Gergana Todorova

  • Requires Subscription PDF (USD 25)

• Setting Up and Working with a Board of Directors: A Guide for Startups

  James Jordan

  • Requires Subscription PDF (USD 25)

• When an FDA Drug Approval Makes Mainstream News: The Announcement of Zulresso, A Media Case Study

  Moira Gunn

  • Requires Subscription PDF (USD 25)

• The Complexity of Pharmaceutical Prices: An Economic Analysis

  Erwin A. Blackstone, Joseph P. Fuhr Jr.

  • Requires Subscription PDF (USD 25)

• The R&D Marketing Interface in Biopharma and MedTech

  Thani Jambulingam

  • Requires Subscription PDF (USD 25)